缬苯那嗪二甲苯磺酸盐 Valbenazine Tosylate

缬苯那嗪二甲苯磺酸盐 Valbenazine Tosylate

一、产品概述

      Valbenazine Tosylate由Neurocrine Biosciences研发，用于治疗亨廷顿舞蹈症和迟发性运动障碍。于2017年4月11日获得美国食品药品监督管理局（FDA）批准上市，化合物专利2029年到期。

二、主要产品

Description	Structural Formula	CAS No.	Category
Valbenazine Tosylate		1639208-54-0	API
2-acetyl-N,N,N,4-tetramethylpentan-1- aminium iodide		1069-62-1	Intermediate
6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride		20232-39-7	Intermediate
(S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanoic acid		13734-41-3	Intermediate

Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.